Peri-implant parameters, tumor necrosis factor-alpha, and interleukin-1 beta levels in vaping individuals

56Citations
Citations of this article
131Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: To the author's knowledge, there has been no study that has assessed clinical, radiographic, and immunological peri-implant parameters among individuals vaping e-cigarette (e-cig). Purpose: This pilot study aimed to compare clinical and radiographic peri-implant parameters and levels of tumor necrosis factor alpha (TNF-α) and interleukin (IL)-1β levels among individuals vaping e-cigs and never smoker (NS). Materials and Methods: Forty-seven individuals vaping e-cigs (group-1) and 45 NS (group-2) were included. Demographic and implant-related data were collected using a structured baseline questionnaire. Peri-implant plaque index (PI), bleeding on probing (BOP), and probing depth (PD) were recorded and peri-implant bone loss (PIBL) were assessed using standardized digital radiographs. Enzyme-linked immunosorbent assay was used to assess the levels of TNF-α and IL-1β in peri-implant sulcular fluid. Results: Bleeding on probing showed statistically significantly higher values in group-2 patients as compared to group-1 patients (P

Cite

CITATION STYLE

APA

Al-Aali, K. A., Alrabiah, M., ArRejaie, A. S., Abduljabbar, T., Vohra, F., & Akram, Z. (2018). Peri-implant parameters, tumor necrosis factor-alpha, and interleukin-1 beta levels in vaping individuals. Clinical Implant Dentistry and Related Research, 20(3), 410–415. https://doi.org/10.1111/cid.12597

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free